196 related articles for article (PubMed ID: 35332268)
1. Loss of deubiquitylase USP2 triggers development of glioblastoma via TGF-β signaling.
Tu Y; Xu L; Xu J; Bao Z; Tian W; Ye Y; Sun G; Miao Z; Chao H; You Y; Liu N; Ji J
Oncogene; 2022 Apr; 41(18):2597-2608. PubMed ID: 35332268
[TBL] [Abstract][Full Text] [Related]
2. Itch E3 ubiquitin ligase positively regulates TGF-β signaling to EMT via Smad7 ubiquitination.
Park SH; Jung EH; Kim GY; Kim BC; Lim JH; Woo CH
Mol Cells; 2015 Jan; 38(1):20-5. PubMed ID: 25518932
[TBL] [Abstract][Full Text] [Related]
3. Smad7 Protein Interacts with Receptor-regulated Smads (R-Smads) to Inhibit Transforming Growth Factor-β (TGF-β)/Smad Signaling.
Yan X; Liao H; Cheng M; Shi X; Lin X; Feng XH; Chen YG
J Biol Chem; 2016 Jan; 291(1):382-92. PubMed ID: 26555259
[TBL] [Abstract][Full Text] [Related]
4. USP26 regulates TGF-β signaling by deubiquitinating and stabilizing SMAD7.
Kit Leng Lui S; Iyengar PV; Jaynes P; Isa ZFBA; Pang B; Tan TZ; Eichhorn PJA
EMBO Rep; 2017 May; 18(5):797-808. PubMed ID: 28381482
[TBL] [Abstract][Full Text] [Related]
5. P144, a Transforming Growth Factor beta inhibitor peptide, generates antitumoral effects and modifies SMAD7 and SKI levels in human glioblastoma cell lines.
Gallo-Oller G; Vollmann-Zwerenz A; Meléndez B; Rey JA; Hau P; Dotor J; Castresana JS
Cancer Lett; 2016 Oct; 381(1):67-75. PubMed ID: 27473823
[TBL] [Abstract][Full Text] [Related]
6. Ubiquitination and regulation of Smad7 in the TGF-β1/Smad signaling of aristolochic acid nephropathy.
Tian Y; Liao F; Wu G; Chang D; Yang Y; Dong X; Zhang Z; Zhang Y; Wu G
Toxicol Mech Methods; 2015; 25(8):645-52. PubMed ID: 26108275
[TBL] [Abstract][Full Text] [Related]
7. USP15 stabilizes TGF-β receptor I and promotes oncogenesis through the activation of TGF-β signaling in glioblastoma.
Eichhorn PJ; Rodón L; Gonzàlez-Juncà A; Dirac A; Gili M; Martínez-Sáez E; Aura C; Barba I; Peg V; Prat A; Cuartas I; Jimenez J; García-Dorado D; Sahuquillo J; Bernards R; Baselga J; Seoane J
Nat Med; 2012 Feb; 18(3):429-35. PubMed ID: 22344298
[TBL] [Abstract][Full Text] [Related]
8. HERC3-Mediated SMAD7 Ubiquitination Degradation Promotes Autophagy-Induced EMT and Chemoresistance in Glioblastoma.
Li H; Li J; Chen L; Qi S; Yu S; Weng Z; Hu Z; Zhou Q; Xin Z; Shi L; Ma L; Huang A; Lu Y
Clin Cancer Res; 2019 Jun; 25(12):3602-3616. PubMed ID: 30862693
[TBL] [Abstract][Full Text] [Related]
9. TSC-22 promotes transforming growth factor β-mediated cardiac myofibroblast differentiation by antagonizing Smad7 activity.
Yan X; Zhang J; Pan L; Wang P; Xue H; Zhang L; Gao X; Zhao X; Ning Y; Chen YG
Mol Cell Biol; 2011 Sep; 31(18):3700-9. PubMed ID: 21791611
[TBL] [Abstract][Full Text] [Related]
10. CD109-mediated degradation of TGF-β receptors and inhibition of TGF-β responses involve regulation of SMAD7 and Smurf2 localization and function.
Bizet AA; Tran-Khanh N; Saksena A; Liu K; Buschmann MD; Philip A
J Cell Biochem; 2012 Jan; 113(1):238-46. PubMed ID: 21898545
[TBL] [Abstract][Full Text] [Related]
11. Loss of KLF4 and consequential downregulation of Smad7 exacerbate oncogenic TGF-β signaling in and promote progression of hepatocellular carcinoma.
Sun H; Peng Z; Tang H; Xie D; Jia Z; Zhong L; Zhao S; Ma Z; Gao Y; Zeng L; Luo R; Xie K
Oncogene; 2017 May; 36(21):2957-2968. PubMed ID: 28192402
[TBL] [Abstract][Full Text] [Related]
12. Axin is a scaffold protein in TGF-beta signaling that promotes degradation of Smad7 by Arkadia.
Liu W; Rui H; Wang J; Lin S; He Y; Chen M; Li Q; Ye Z; Zhang S; Chan SC; Chen YG; Han J; Lin SC
EMBO J; 2006 Apr; 25(8):1646-58. PubMed ID: 16601693
[TBL] [Abstract][Full Text] [Related]
13. Current perspectives on inhibitory SMAD7 in health and disease.
de Ceuninck van Capelle C; Spit M; Ten Dijke P
Crit Rev Biochem Mol Biol; 2020 Dec; 55(6):691-715. PubMed ID: 33081543
[TBL] [Abstract][Full Text] [Related]
14. Bardoxolone ameliorates TGF-β1-associated renal fibrosis through Nrf2/Smad7 elevation.
Song MK; Lee JH; Ryoo IG; Lee SH; Ku SK; Kwak MK
Free Radic Biol Med; 2019 Jul; 138():33-42. PubMed ID: 31059771
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-181c Suppresses the Biological Progression of Osteosarcoma via Targeting SMAD7 and Regulating Transforming Growth Factor-β (TGF-β) Signaling Pathway.
Fu Y; Tang Y; Wang J; Guo Z
Med Sci Monit; 2019 Jun; 25():4801-4810. PubMed ID: 31251735
[TBL] [Abstract][Full Text] [Related]
16. The phosphatidylinositol 3-kinase/Akt pathway regulates transforming growth factor-{beta} signaling by destabilizing ski and inducing Smad7.
Band AM; Björklund M; Laiho M
J Biol Chem; 2009 Dec; 284(51):35441-9. PubMed ID: 19875456
[TBL] [Abstract][Full Text] [Related]
17. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
[TBL] [Abstract][Full Text] [Related]
18. YAP/TAZ regulates TGF-β/Smad3 signaling by induction of Smad7 via AP-1 in human skin dermal fibroblasts.
Qin Z; Xia W; Fisher GJ; Voorhees JJ; Quan T
Cell Commun Signal; 2018 Apr; 16(1):18. PubMed ID: 29695252
[TBL] [Abstract][Full Text] [Related]
19. Targeting Stat3 and Smad7 to restore TGF-β cytostatic regulation of tumor cells in vitro and in vivo.
Luwor RB; Baradaran B; Taylor LE; Iaria J; Nheu TV; Amiry N; Hovens CM; Wang B; Kaye AH; Zhu HJ
Oncogene; 2013 May; 32(19):2433-41. PubMed ID: 22751114
[TBL] [Abstract][Full Text] [Related]
20. Elevating CLIC4 in Multiple Cell Types Reveals a TGF- Dependent Induction of a Dominant Negative Smad7 Splice Variant.
Shukla A; Yang Y; Madanikia S; Ho Y; Li M; Sanchez V; Cataisson C; Huang J; Yuspa SH
PLoS One; 2016; 11(8):e0161410. PubMed ID: 27536941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
